| 1 |
33096154 | Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer. | 2020 Dec |
2 |
| 2 |
29031537 | Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression. | 2018 Jan |
2 |
| 3 |
28609310 | Blockade of GLUT1 by WZB117 resensitizes breast cancer cells to adriamycin. | 2017 Sep |
8 |
| 4 |
27569031 | Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models. | 2016 Nov |
1 |
| 5 |
24467213 | Identification of chemoresistance-related cell-surface glycoproteins in leukemia cells and functional validation of candidate glycoproteins. | 2014 Mar 7 |
1 |
| 6 |
24641416 | HIF-1α and GLUT1 gene expression is associated with chemoresistance of acute myeloid leukemia. | 2014 |
1 |
| 7 |
25101238 | Role of GLUT1 in regulation of reactive oxygen species. | 2014 |
2 |
| 8 |
24098980 | Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin. | 2013 Dec |
6 |
| 9 |
20870738 | DNA damage-induced modulation of GLUT3 expression is mediated through p53-independent extracellular signal-regulated kinase signaling in HeLa cells. | 2010 Nov |
1 |
| 10 |
16595493 | Stunning and its effect on 3H-FDG uptake and key gene expression in breast cancer cells undergoing chemotherapy. | 2006 Apr |
4 |